Navigation Links
Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases
Date:11/6/2007

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- A new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) finds that America's pharmaceutical research companies are now testing 338 new medicines to help treat infectious diseases, including 11 medicines and four vaccines to treat staphococcal infections. This is particularly important in light of increased public concern about the spread of methicillin-resistant staphylococcus aureus (MRSA) infections -- a strain of staph that has become resistant to current treatments.

"Staph poses a serious pubic health threat that we are committed to fighting," PhRMA President and CEO Billy Tauzin said. "America's pharmaceutical research companies are working hard to develop new medicines that will treat staph and even prevent patients from infection in the first place."

Although scientists say infectious diseases will never be completely eliminated, new research and commitment of resources by both the government and pharmaceutical research companies can help meet the continuing - and ever-changing - threat from infectious diseases. These 338 medicines in development will help combat humankind's oldest and most tenacious enemy: infectious diseases.

Among the new medicines now being tested are 146 vaccines to prevent diseases such as smallpox and staph; 83 antibiotics/antibacterials to treat infections such as pneumonia and tuberculosis; 75 antivirals to treat such viruses as hepatitis and influenza; and, 25 antifungals.

According to the report, the medicines in development include:

--A first-in-class medicine designed specifically to inhibit drug-resistant strains of Staphylococcus aureus.

--A medicine for the treatment of hepatitis C that is part of a new class of drugs to regulate innate immunity.

--A medicine that stops the life cycle of the bacterium that causes tuberculosis.

Other medicines are in development for treatment of fu
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... VALLEY, Pa. , Sept. 22, 2014 /PRNewswire/ ... delivering innovative solutions for medical and surgical procedures, ... reached a deal with Munich ... of Kick ® Navigation. This agreement applies ... distribution for cross-disciplinary U.S. sales and all distribution ...
(Date:9/22/2014)... CHICAGO, Ill. , Sept. 22, 2014 /PRNewswire/ ... data from several clinical studies evaluating potential new ... presented at the upcoming 2014 European Society of ... Madrid, Spain . Data being ... evaluating the safety and efficacy of veliparib (ABT-888), ...
(Date:9/22/2014)... Sept. 22, 2014  Sutro Biopharma today announced that ... one of 2014,s Fierce 15 biotechnology companies, designating it ... in the industry.  "Sutro has earned ... as well as industry partners for what promises to ... bispecifics," says John Carroll , editor of ...
Breaking Medicine Technology:Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3
... of Cimzia® (certolizumab pegol; CZP) to current therapy ... function and reduced disease activity in a diverse ... those seen in daily clinical practice (including those ... data were presented during the American College of ...
... CryoLife, Inc. (NYSE: CRY ), an ... today that it will participate in the Lazard Capital Markets ... New York City. Steven G. Anderson, president and ... Tuesday, November 16, 2010 at 4:10 p.m., Eastern Time. ...
Cached Medicine Technology:New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 2New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 3New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 4New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 5New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 6New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 7New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 8New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 9New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 10CryoLife to Present at Lazard Capital Markets 7th Annual Healthcare Conference 2
(Date:9/22/2014)... September 22, 2014 Locating the top ... is now easier using the Quotes Pros portal online. ... to local universal life insurance pricing from different companies ... plans that are easily viewed when using the finder ... lengths of coverage. The plan data can be reviewed ...
(Date:9/22/2014)... New York, NY (PRWEB) September 22, 2014 ... pain on the side of the hip , ... for hip bursitis treatment in Manhattan. This treatment is now offered ... bursitis, which is also called trochanteric bursitis, occurs when ... is a fluid-filled sac in the hip, between the ...
(Date:9/22/2014)... a whole eye transplant seems futuristic, if not ... U.S. Department of Defense, researchers at University of ... someday make implantation of an entire, functional eye ... be a holy grail for vision restoration," said ... grant co-recipient with colleagues at University of Pittsburg ...
(Date:9/22/2014)... 2014 This Flash Report is a ... needs for the Prostate Cancer market. , Download the ... strategies for any launching Prostate Cancer product:, ... an increasingly crowded market , Understanding stakeholder ... identifying community-based thought leaders and stakeholders ,Download the ...
(Date:9/22/2014)... 2014 The Workgroup for ... nonprofit authority on the use of health IT ... findings from its recent industry survey on the ... within electronic transactions adopted under the Health Insurance ... survey from August 20 to September 5, which ...
Breaking Medicine News(10 mins):Health News:Universal Life Insurance Prices for Adults Added to National Insurer Portal Online 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Looking ahead: Whole eye transplant under development 2Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3
... to increase participation in the USDA,s Summer Food ... Solutions Minnesota and Second Harvest Heartland today announced ... Children,s Fund Summer Lunch Program ( ... 200,000 additional meals for Minnesota children this summer. ...
... Minneapolis-based Courage Center, a nonprofit rehabilitation and resource center, is ... weeks to Friday, June 12, 2009:, , ... Phillips Awards are presented each year by Courage Center to people ... Three people will be recognized for this employment award and receive ...
... who receive one of the standard treatments for localized prostate ... outcome. , But for the small group whose prostate ... treatment isn,t effective. , The study a collaboration ... Ford Hospital and Fox Chase Cancer Center shows that ...
... Journalists to Examine Health Policy Issues In-depthMENLO ... Family Foundation today announced the nine journalists ... Media Fellowships in Health program. The ... will engage in group site visits focused ...
... With the recent news that one in three common cancers may be ... find it is easier in summer to change their lifestyles than during ... overall health and fight against cancer - inside and out. , ... ...
... Dr. Peter Burrows from the Arizona Center-Vasectomy/Urology, a specialist in ... Seminar on Saturday June 6th. The program, to be ... the latest treatment options for two of the most common ... Enlarged Prostate) and Erectile Dysfunction. A question and answer ...
Cached Medicine News:Health News:Minnesota Vikings, Hunger Solutions Minnesota and Second Harvest Heartland to Help Secure 200,000 Meals for Hungry Minnesota Children This Summer 2Health News:Minnesota Vikings, Hunger Solutions Minnesota and Second Harvest Heartland to Help Secure 200,000 Meals for Hungry Minnesota Children This Summer 3Health News:Minnesota Vikings, Hunger Solutions Minnesota and Second Harvest Heartland to Help Secure 200,000 Meals for Hungry Minnesota Children This Summer 4Health News:Deadline Extended for Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award 2Health News:Why some prostate cancer returns 2Health News:Nine Journalists Named as 2009 Kaiser Media Fellows 2Health News:Nine Journalists Named as 2009 Kaiser Media Fellows 3Health News:Nine Journalists Named as 2009 Kaiser Media Fellows 4Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 2Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 3Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 4Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 5Health News:Enlarged Prostate and Erectile Dysfunction Are Subjects of Free Men's Health Seminar 2
... ideal video magnification solution for flexibility ... camera attached to a small flexible ... a mini xY reading table designed ... Minimates versatility allows you to easily ...
... and portability together in one product. Flipperport ... resolution color camera that captures the image, ... display the magnified image. This self contained, ... use and comfort. FlipperPort can easily connect ...
... full-color, auto-focus, desktop video magnifier. Designed with ... enables the user to view images in ... positive or high contrast negative. The first ... enables the user to use simple voice ...
... general purpose incubators designed to ... and uniformity required for the ... versatile microprocessor controlled incubators feature ... easy-to-read digital display, and built-in ...
Medicine Products: